.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
US Department of Justice
Argus Health
Cerilliant
Moodys
Harvard Business School
Novartis
Cipla
US Army
UBS

Generated: June 27, 2017

DrugPatentWatch Database Preview

Vasopressin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for vasopressin and what is the scope of vasopressin freedom to operate?

Vasopressin
is the generic ingredient in two branded drugs marketed by Par Sterile Products and Parke Davis, and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for vasopressin. One supplier is listed for this compound.

Summary for Generic Name: vasopressin

Tradenames:2
Patents:2
Applicants:2
NDAs:2
Drug Master File Entries: see list5
Suppliers / Packagers: see list1
Clinical Trials: see list143
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:vasopressin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
VASOSTRICT
vasopressin
SOLUTION;IV (INFUSION)204485-002Dec 17, 2016RXYesYes9,375,478► Subscribe ► Subscribe
Par Sterile Products
VASOSTRICT
vasopressin
SOLUTION;IV (INFUSION)204485-001Apr 17, 2014RXYesYes9,375,478► Subscribe ► Subscribe
Parke Davis
PITRESSIN TANNATE
vasopressin tannate
INJECTABLE;INJECTION003402-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cipla
Chinese Patent Office
Accenture
Dow
Moodys
QuintilesIMS
Harvard Business School
Farmers Insurance
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot